Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy
Open Access
- 1 December 2001
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 20 (6) , 1106-1112
- https://doi.org/10.1016/s1010-7940(01)00984-8
Abstract
Objective: Chemotherapy of stage IIIA non-small cell lung cancer (NSCLC) using second generation, cisplatin-based combinations has shown to improve tKeywords
This publication has 20 references indexed in Scilit:
- Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 casesThe Annals of Thoracic Surgery, 1997
- Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIa (N2) non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Pretreatment minimal staging for non-small cell lung cancer: an updated consensus reportLung Cancer, 1994
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patientsThe Annals of Thoracic Surgery, 1993
- Randomized trial of neoadjuvant therapy for lung cancer: Interim analysisThe Annals of Thoracic Surgery, 1992
- Clinical Staging of Primary Lung CancerAmerican Review of Respiratory Disease, 1983
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958